Biotron Limited (ASX:BIT)
Australia flag Australia · Delayed Price · Currency is AUD
0.0020
-0.0005 (-20.00%)
Sep 3, 2026, 9:59 AM AEST

Biotron Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Other Revenue
0.531.811.651.431.56
0.531.811.651.431.56
Revenue Growth
-71.00%10.24%14.94%-8.16%6.61%
Gross Profit
0.531.811.651.431.56
Selling, General & Admin
1.241.511.41.631.12
Research & Development
0.680.543.623.232.82
Other Operating Expenses
0.150.090.090.140.35
Operating Expenses
2.082.155.155.044.34
Operating Income
-1.56-0.34-3.51-3.61-2.78
Interest Expense
--0.01-0-0-0.01
Interest & Investment Income
0.040.030.070.120
Pretax Income
-1.52-0.32-3.44-3.49-2.78
Net Income
-1.52-0.32-3.44-3.49-2.78
Net Income to Common
-1.52-0.32-3.44-3.49-2.78
Net Income Growth
-----
Shares Outstanding (Basic)
2,074999902821702
Shares Outstanding (Diluted)
2,074999902821702
Shares Change
107.51%10.76%9.91%16.94%-
EPS (Basic)
-0.00-0.00-0.00-0.00-0.00
EPS (Diluted)
-0.00-0.00-0.00-0.00-0.00
EPS Growth
-----

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-1.78-0.57-3.57-3.29-2.44
Free Cash Flow Per Share
-0.00-0.00-0.00-0.00-0.00
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Operating Margin
-295.91%-18.68%-213.12%-252.08%-178.32%
Profit Margin
-288.72%-17.57%-208.89%-244.03%-178.44%
Free Cash Flow Margin
-337.86%-31.37%-216.92%-229.87%-156.31%
EBITDA
-1.55-0.33-3.5-3.6-2.77
EBITDA Margin
-295.55%-18.40%-213.02%-251.63%-177.64%
D&A For EBITDA
0000.010.01
EBIT
-1.56-0.34-3.51-3.61-2.78
EBIT Margin
-295.91%-18.68%-213.12%-252.08%-178.32%